MedTrace Logo

Consensus And Norms for Medical Visualization Academic Standards Study - A Modified Delphi Study

NCT07684703 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-08-04

No results posted yet for this study

Summary

The goal of this observational study (modified Delphi consensus study) is to establish an international expert consensus on professional standards for medical visualization in medical visualization experts from from around the world, each with a minimum of five years of relevant professional experience. The specific objectives are:

1. to develop and validate core consensus statements on professional standards for medical visualization (consensus threshold ≥75%).
2. to quantify the distribution of divergence in professional opinion.

Participants will:

Fill out a short background survey about their job title, training, work setting, location, and experience with AI image tools.

Rate 10 statements about medical visualization standards on a scale from 1 (Strongly Disagree) to 5 (Strongly Agree). These statements cover three topics: accuracy, accessibility, and ethics. Participants will complete up to 3 rounds of anonymous online surveys.

Write comments to explain why they disagree with any statement they rate 1 or 2.

Between rounds, review a summary showing their own earlier ratings and the group's overall results (with no names attached). Then, re-rate any statements the group has not yet agreed on.

Conditions

  • Medical Visualization
  • Medical Illustration
  • Consensus

Interventions

OTHER

Delphi procedure

The study involves generating consensus statements by experts on medical visualization from around the world on professional standards for medical illustration and visualization - covering accuracy and scientific rigor, accessibility and diversity, and disclosure and ethics - using a modified Delphi process.

Sponsors & Collaborators

Principal Investigators

  • Monal, Yu-Hsuan Chang, M.D. · National Taiwan University Hospital

Eligibility

Min Age
27 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-15
Primary Completion
2027-04-30
Completion
2027-12-31

Countries

  • Taiwan

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07684703 on ClinicalTrials.gov